Over 200 California Auctions End Today - Bid Now

Johnson & Johnson to acquire Auris Health for $3.4 billion

por Thomas Dworetzky, Contributing Reporter | February 19, 2019
Business Affairs

“Health care providers and surgeons are shifting from volume to value-based care and need technologies and solutions that help reduce costs, improve outcomes and enhance patient satisfaction,” Ciro Romer, company group chair of Johnson & Johnson’s orthopedic's business, DePuy Synthes, told HCB News at the time, adding, “in order for robotic-assisted surgery to continue to play a long-term role in this new environment, the technology must evolve from being a costly surgical add-on into part of a holistic platform that supports customers and patients throughout the episode of care.”

It also fits with the company's earlier strategic partnership to develop the Verb Surgical Platform.

“We are very committed to our partnership with Verily on the development of the Verb Surgical Platform. Collectively, these technologies, together with our market-leading medical implants and solutions, create the foundation of a comprehensive digital ecosystem to help support the surgeon and patient before, during and after surgery,” said McEvoy.

The prototype of the Verb platform was delivered to collaboration partners in January, 2017. Partners include Ethicon Endo-Surgery and Verily Life Sciences – formerly Google Life Sciences.

The prototype had all five “key” tech elements under development by the partnership – robotics, visualization, advanced instrumentation, data analytics, and connectivity.

"This is a tremendous achievement for Verb and our collaboration partners at Ethicon, and Verily," said Verb Surgical CEO Scott Huennekens at the time.

Full development by over 300 employees around the globe is now underway, according to the Verb website.

These deals are all part of the Johnson & Johnson plan to create “a connected digital ecosystem centered around using data to improve patient outcomes, that leverages world-class robotic technology,” according to the company.

Back to HCB News

You Must Be Logged In To Post A Comment